Starlix (nateglinide), a new oral tablet for type 2 diabetes
February 2001
You'll see ads for Starlix (nateglinide), a new oral tablet for type 2 diabetes.
Think of it as a shorter-acting Prandin (repaglinide).
Both meds are taken before meals to stimulate insulin release...but Starlix has a shorter duration.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote